Literature DB >> 12088939

Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency.

Yuwen Hu1, Jeffrey P Carpenter, Albert T Cheung.   

Abstract

IMPLICATIONS: Serum potassium concentration should be measured immediately before operation to detect hyperkalemia in heart failure patients treated with spironolactone. Renal insufficiency, advanced age, potassium supplementation, decompensated congestive heart failure, and a spironolactone dose larger than 25 mg/d increase the risk of hyperkalemia as a consequence of spironolactone therapy.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12088939     DOI： 10.1097/00000539-200207000-00006

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  4 in total

1.  Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.

Authors:  Eike Wrenger; Regina Müller; Michael Moesenthin; Tobias Welte; Jürgen C Frölich; Klaus H Neumann
Journal:  BMJ       Date:  2003-07-19

2.  [Successful resuscitation of a patient with hyperkalemic cardiac arrest by emergency hemodiafiltration].

Authors:  D Gütlich; M Hochscherf; H-B Hopf
Journal:  Anaesthesist       Date:  2005-11       Impact factor: 1.041

3.  Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases.

Authors:  Omalhassan Amir; Yahaya Hassan; Azmi Sarriff; Ahmed Awaisu; Noorizan Abd Aziz; Omar Ismail
Journal:  Pharm World Sci       Date:  2009-03-03

4.  Severe hyperkalemia requiring hospitalization: predictors of mortality.

Authors:  Jung Nam An; Jung Pyo Lee; Hee Jung Jeon; Do Hyoung Kim; Yun Kyu Oh; Yon Su Kim; Chun Soo Lim
Journal:  Crit Care       Date:  2012-11-21       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.